
-
2009 September 28
Company Description
Sprint Bioscience AB offers a modular gene-to-lead drug discovery platform for fragment-based drug discovery, including protein expression
Sprint Bioscience AB offers a modular gene-to-lead drug discovery platform for fragment-based drug discovery, including protein expression and purification, fragment screening, X-ray crystallography, and expansion of fragments into a patented lead series. Sprint Bioscience is based in Stockholm, Sweden.
-
Manufacturer:
Science and Engineering -
Formed:
September 28, 2009 -
Company Website:
-
Company E-mail:
-
Company Address:
Teknikringen 38AStockholmSweden -
CEO:
- Anne-Marie Wenthzel
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits